Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

PURPOSE. Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs). Published data suggest that EGFR addiction persists after development of TKI acquired resistance, leading many clini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Goldberg, Sarah B., Oxnard, Geoffrey R., Digumarthy, Subba, Muzikansky, Alona, Jackman, David M., Lennes, Inga T., Sequist, Lecia V.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Lung Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825307/
https://ncbi.nlm.nih.gov/pubmed/24072220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0168
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados